Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman.
Ripamonti
Diego
D
Maggiolo
Franco
F
Suter
Fredy
F
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D016049:Didanosine / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D063065:Organophosphonates / Q000009:adverse effects*; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine; D016049:Didanosine